• Je něco špatně v tomto záznamu ?

Determination of dasatinib in the tablet dosage form by ultra high performance liquid chromatography, capillary zone electrophoresis, and sequential injection analysis

AG. Gonzalez, L. Taraba, J. Hraníček, P. Kozlík, P. Coufal,

. 2017 ; 40 (2) : 400-406. [pub] 20161128

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016935

Dasatinib is a novel oral prescription drug proposed for treating adult patients with chronic myeloid leukemia. Three analytical methods, namely ultra high performance liquid chromatography, capillary zone electrophoresis, and sequential injection analysis, were developed, validated, and compared for determination of the drug in the tablet dosage form. The total analysis time of optimized ultra high performance liquid chromatography and capillary zone electrophoresis methods was 2.0 and 2.2 min, respectively. Direct ultraviolet detection with detection wavelength of 322 nm was employed in both cases. The optimized sequential injection analysis method was based on spectrophotometric detection of dasatinib after a simple colorimetric reaction with folin ciocalteau reagent forming a blue-colored complex with an absorbance maximum at 745 nm. The total analysis time was 2.5 min. The ultra high performance liquid chromatography method provided the lowest detection and quantitation limits and the most precise and accurate results. All three newly developed methods were demonstrated to be specific, linear, sensitive, precise, and accurate, providing results satisfactorily meeting the requirements of the pharmaceutical industry, and can be employed for the routine determination of the active pharmaceutical ingredient in the tablet dosage form.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016935
003      
CZ-PrNML
005      
20180515103358.0
007      
ta
008      
180515s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jssc.201600950 $2 doi
035    __
$a (PubMed)27805766
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Gonzalez, Aroa Garcia $u GlaxoSmithKline, Currabinny, Carrigaline, Co. Cork, Ireland. Faculty of Science, Department of Analytical Chemistry, Charles University, Czech Republic.
245    10
$a Determination of dasatinib in the tablet dosage form by ultra high performance liquid chromatography, capillary zone electrophoresis, and sequential injection analysis / $c AG. Gonzalez, L. Taraba, J. Hraníček, P. Kozlík, P. Coufal,
520    9_
$a Dasatinib is a novel oral prescription drug proposed for treating adult patients with chronic myeloid leukemia. Three analytical methods, namely ultra high performance liquid chromatography, capillary zone electrophoresis, and sequential injection analysis, were developed, validated, and compared for determination of the drug in the tablet dosage form. The total analysis time of optimized ultra high performance liquid chromatography and capillary zone electrophoresis methods was 2.0 and 2.2 min, respectively. Direct ultraviolet detection with detection wavelength of 322 nm was employed in both cases. The optimized sequential injection analysis method was based on spectrophotometric detection of dasatinib after a simple colorimetric reaction with folin ciocalteau reagent forming a blue-colored complex with an absorbance maximum at 745 nm. The total analysis time was 2.5 min. The ultra high performance liquid chromatography method provided the lowest detection and quantitation limits and the most precise and accurate results. All three newly developed methods were demonstrated to be specific, linear, sensitive, precise, and accurate, providing results satisfactorily meeting the requirements of the pharmaceutical industry, and can be employed for the routine determination of the active pharmaceutical ingredient in the tablet dosage form.
650    _2
$a farmaceutická chemie $x metody $x normy $7 D002626
650    12
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a dasatinib $x analýza $7 D000069439
650    12
$a elektroforéza kapilární $7 D019075
650    _2
$a lidé $7 D006801
650    _2
$a limita detekce $7 D057230
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    12
$a spektrofotometrie $7 D013053
650    _2
$a tablety $x chemie $x normy $7 D013607
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Taraba, Lukáš $u Faculty of Science, Department of Analytical Chemistry, Charles University, Czech Republic.
700    1_
$a Hraníček, Jakub $u Faculty of Science, Department of Analytical Chemistry, Charles University, Czech Republic.
700    1_
$a Kozlík, Petr $u Faculty of Science, Department of Analytical Chemistry, Charles University, Czech Republic.
700    1_
$a Coufal, Pavel $u Faculty of Science, Department of Analytical Chemistry, Charles University, Czech Republic.
773    0_
$w MED00006463 $t Journal of separation science $x 1615-9314 $g Roč. 40, č. 2 (2017), s. 400-406
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27805766 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103531 $b ABA008
999    __
$a ok $b bmc $g 1300559 $s 1013775
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 40 $c 2 $d 400-406 $e 20161128 $i 1615-9314 $m Journal of separation science $n J Sep Sci $x MED00006463
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace